Insiders who reported open-market trades in the last 12 months at the companies James C. Momtazee files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
James C. Momtazee is a corporate insider, tracked as Director of Roivant Sciences Ltd. (ROIV). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James C. Momtazee submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
InsiderAlpha's records for James C. Momtazee go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
